XML 25 R14.htm IDEA: XBRL DOCUMENT v3.25.1
FINANCIAL INSTRUMENTS AT FAIR VALUE
3 Months Ended
Mar. 31, 2025
Investments, All Other Investments [Abstract]  
FINANCIAL INSTRUMENTS AT FAIR VALUE

NOTE 8: FINANCIAL INSTRUMENTS AT FAIR VALUE

 

Financial instruments:

 

The Company has financial instruments measured at level 3 arising from the June 2024 Facility Agreement, the First July 2024 Facility Agreement and the Second July 2024 Facility Agreement (see notes 7.E, 7.F, 7.G).

 

The fair value of the financial instruments as of December 31, 2024, was calculated using the following unobservable inputs: share price: $0.472, expected volatility: 148%, exercise price: $1.00, risk-free interest rate: 4.24%-4.32%, expected life: 0.46-0.50 years.

 

The fair value of the financial instruments as of March 31, 2025, was calculated using the following unobservable inputs: share price: $3.9, expected volatility: 150%, exercise price: $1.00, risk-free interest rate: 4.32%-4.35%, expected life: 0.21-0.34 years.

 

The following table presents the financial instruments that were measured at fair value through profit or loss:

 

    Embedded
derivatives
 
Balance as of January 1, 2025     29  
Net changes at fair value recognized through profit or loss    

2,723

 
Balance as of March 31, 2025    

2,752

 

  

    Embedded
derivatives
 
Balance as of January 1, 2024     -  
Embedded derivatives recorded in connection with the June 2024 Facility Agreement, the First July 2024 Facility Agreement and the Second July 2024 Facility Agreement     40  
Net changes at fair value recognized through profit or loss     (11 )
Balance as of December 31, 2024     29